AUTL
Autolus Therapeutics
AUTL
AUTL
66 hedge funds and large institutions have $106M invested in Autolus Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
1.61% less ownership
Funds ownership: 55.92% → 54.3% (-1.6%)
27% less capital invested
Capital invested by funds: $144M → $106M (-$38.2M)
33% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 21
Holders
66
Holding in Top 10
1
Calls
$195K
Puts
$1K
Top Buyers
| 1 | +$192K | |
| 2 | +$156K | |
| 3 | +$118K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$55.4K |
| 5 |
LPL Financial
San Diego,
California
|
+$50K |
Top Sellers
| 1 | -$2.16M | |
| 2 | -$637K | |
| 3 | -$394K | |
| 4 |
Millennium Management
New York
|
-$339K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$133K |